Literature DB >> 15242947

Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response.

Salma Al-Darmaki1, Kandi Knightshead, Yuichi Ishihara, Al Best, Harvey A Schenkein, John G Tew, Suzanne E Barbour.   

Abstract

Localized aggressive periodontitis (LAgP) is a chronic inflammatory disease characterized by severe destruction of periodontal tissues surrounding the first molars and incisors. LAgP subjects produce large amounts of immunoglobulin G2 (IgG2) antibody against oral pathogens, and this response is inversely correlated with the severity of disease. We previously demonstrated that platelet-activating factor (PAF) is required for optimal IgG2 responses. The present investigation was designed to determine the mechanism of IgG2 induction by PAF. Exogenous PAF acetylhydrolase suppressed approximately 80% of pokeweed mitogen-stimulated IgG2 production, confirming that PAF is essential for optimal responses. PAF-activated leukocytes produced gamma interferon (IFN-gamma), a Th1 cytokine that has been associated with IgG2 responses in previous studies. The monocyte-derived cytokines interleukin-12 (IL-12) and IL-18 are upstream of IFN-gamma production, and IgG2 production was suppressed by neutralizing antibodies against these proteins. In addition, PAF induced monocyte-derived dendritic cells (DC) but not macrophages (MPhi) to secrete IL-12 and IL-18. This observation was interesting because monocyte differentiation in LAgP subjects is skewed to the DC phenotype. Although other investigators have implicated IFN-gamma in IgG2 production, its precise role in this response is controversial. Our studies suggest that IFN-gamma induces isotype switching to IgG2 but only in concert with the Th2 cytokine IL-4. Thus, it appears that the unique PAF metabolism of LAgP monocytes or DC promotes Th1 responses that are essential for optimal IgG2 antibody production. As IgG2 antibodies opsonize oral bacteria and promote their clearance and destruction, these alterations in PAF metabolism may be essential for limiting disease severity in LAgP patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242947      PMCID: PMC440608          DOI: 10.1128/CDLI.11.4.720-728.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  59 in total

1.  Integrating signals from IFN-gamma and IL-4 by B cells: positive and negative effects on CD40 ligand-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE, and IgG2a.

Authors:  J Hasbold; J S Hong; M R Kehry; P D Hodgkin
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

2.  IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines.

Authors:  A Soininen; I Seppälä; T Nieminen; J Eskola; H Käyhty
Journal:  Vaccine       Date:  1999-04-09       Impact factor: 3.641

3.  ICOS is essential for effective T-helper-cell responses.

Authors:  A Tafuri; A Shahinian; F Bladt; S K Yoshinaga; M Jordana; A Wakeham; L M Boucher; D Bouchard; V S Chan; G Duncan; B Odermatt; A Ho; A Itie; T Horan; J S Whoriskey; T Pawson; J M Penninger; P S Ohashi; T W Mak
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

4.  Altered chemotactic behavior of crevicular PMNs in different forms of periodontitis.

Authors:  B Sigusch; S Eick; W Pfister; G Klinger; E Glockmann
Journal:  J Clin Periodontol       Date:  2001-02       Impact factor: 8.728

5.  Detection of functional platelet-activating factor receptors on human tonsillar B lymphocytes.

Authors:  Y Bastien; B J Toledano; N Mehio; L Cameron; B Lamoukhaid; P Renzi; Q Hamid; B D Mazer
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

6.  Non-redundant roles for interleukin-1 alpha and interleukin-1 beta in regulating human IgG2.

Authors:  Y Ishihara; J B Zhang; M Fakher; A M Best; H A Schenkein; S E Barbour; J G Tew
Journal:  J Periodontol       Date:  2001-10       Impact factor: 6.993

7.  Antibody reactive with Porphyromonas gingivalis serotypes K1-6 in adult and generalized early-onset periodontitis.

Authors:  J V Califano; R E Schifferle; J C Gunsolley; A M Best; H A Schenkein; J G Tew
Journal:  J Periodontol       Date:  1999-07       Impact factor: 6.993

8.  Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases.

Authors:  G Emingil; S Cinarcik; H Baylas; A Hüseyinov
Journal:  J Periodontol       Date:  2001-08       Impact factor: 6.993

9.  Regulation of immunoglobulin G2 production by prostaglandin E(2) and platelet-activating factor.

Authors:  Y Ishihara; J B Zhang; S M Quinn; H A Schenkein; A M Best; S E Barbour; J G Tew
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 10.  Platelet-activating factor and related lipid mediators.

Authors:  S M Prescott; G A Zimmerman; D M Stafforini; T M McIntyre
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

View more
  6 in total

Review 1.  Dendritic cells at the oral mucosal interface.

Authors:  C W Cutler; R Jotwani
Journal:  J Dent Res       Date:  2006-08       Impact factor: 6.116

Review 2.  Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists.

Authors:  Christopher W Cutler; Yen-Tung A Teng
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

3.  IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.

Authors:  Kaustuv Banerjee; P J Klasse; Rogier W Sanders; Florencia Pereyra; Elizabeth Michael; Min Lu; Bruce D Walker; John P Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2010-04       Impact factor: 2.205

4.  Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis.

Authors:  Ravi P Sahu; Amal A Kozman; Yongxue Yao; Sonia C DaSilva; Samin Rezania; Kellie C Martel; Simon J Warren; Jeffrey B Travers; Raymond L Konger
Journal:  Carcinogenesis       Date:  2012-01-04       Impact factor: 4.944

Review 5.  Multiple beneficial health effects of natural alkylglycerols from shark liver oil.

Authors:  Anne-Laure Deniau; Paul Mosset; Frédérique Pédrono; Romain Mitre; Damien Le Bot; Alain B Legrand
Journal:  Mar Drugs       Date:  2010-07-19       Impact factor: 5.118

6.  Boosting Adaptive Immunity: A New Role for PAFR Antagonists.

Authors:  Marianna M Koga; Bruna Bizzarro; Anderson Sá-Nunes; Francisco J Rios; Sonia Jancar
Journal:  Sci Rep       Date:  2016-12-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.